PARIS, July 30 — A Singapore-based organisation announced Thursday it will develop an Ebola vaccine dubbed the “most promising” to fight back against a deadly outbreak in the...

The Singapore-based Hilleman Laboratories announced it would advance the rVSV Bundibugyo jab so it can be tested on humans during clinical trials.

PARIS, July 30 — A Singapore-based organisation announced Thursday it will develop an Ebola vaccine dubbed the “most promising” to fight back against a deadly outbreak in the...